Antibiotic
Algorithm offers narrower- spectrum antibiotic recommendations than those of clinical practice
CARB-X grants Day Zero Diagnostics $6.2M for development of diagnostic tool
Day Zero Diagnostics Inc. has been awarded up to $6.2 million in funding from Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, or CARB-X, to accelerate the development of a new diagnostics system for combatting drug-resistant bacteria using machine learning and whole-genome sequencing.
Fluoroquinolone use remains target for stewardship despite decrease in inpatient use
Flu diagnosis, vaccination curbs unnecessary antibiotic use
Flu diagnosis, vaccination curbs unnecessary antibiotic use
ID specialists improve adherence to antibiotic stewardship principles in hospitals
Dabigatran with P-glycoprotein inhibitors may increase bleeding risk in AF, normal kidney function
Removing ESBL labeling in EMRs reduces carbapenem use for infections
Using Clinical and Laboratory Standards Institute, or CLSI, revised breakpoints and omitting extended-spectrum beta-lactamase, or ESBL, labeling in electronic medical records decreased the prescribing of carbapenem antibiotics and increased beta-lactam/beta-lactamase inhibitor use for infections due to ESBL producers, according to a single-center retrospective chart analysis.
Oral antibiotic regimen for PWID with invasive infections reduces readmission rates
All-cause readmission rates at 90 days among people who inject drugs and left the hospital against medical advice decreased when they were prescribed oral antibiotic therapy — including partial IV therapy and partial oral therapy — compared with patients who were not prescribed any antibiotics, according to findings in Clinical Infectious Diseases.